Talk:Gadofosveset

Propose article title change
I propose that the title of this article be changed from Gadofosveset to Gadofosveset trisodium. There are 2 linked reasons for this. --The chemistds (talk) 13:28, 1 January 2012 (UTC)
 * The structure displayed in the Drugbox is the trisodium salt (and not Gadofosveset which would not have the 3 sodium ions)
 * The formulation of the drug that is currently referred to in the text and the sparse references section would be as the trisodium salt.


 * The policy is to use the International Nonproprietary Name, which I suppose is gadofosveset, as the counter ion is normally only included for quaternary ammonium compounds. Please correct me if I am mistaken. (See WP:MOSMED, WP:PHARMMOS.) --ἀνυπόδητος (talk) 17:01, 1 January 2012 (UTC)


 * The is not really about the choice of name it is about making it clear what compound is the subject of this article. If the article is about the parent compound Gadofosveset, the title is fine but the structure image is incorrect and it should be made clear that the two trade names refer to the trisoodium salt. If the article is about the therapeutic component used in the formulation of the marketed drug then the image is correct but the title should be altered to reflect that.

I can see that you could have a title the parent compound and a chembox for the sodium salt but there this will require more more to maintain the clear distinction within the article. My choice of suggesting that the title be changed to Gadofosveset trisodium was purely based on the fact that all of the information currently included in the article trade names, refs and Chembox are about the trisodium salt and there is no information at all about the parent acid. --The chemistds (talk) 09:09, 6 January 2012 (UTC)